Director of Pharmacokinetics
NCATS/NIH, Maryland, United States
Dr. Xin Xu is a Principal Investigator and Director of Pharmacokinetics at National Center for Advancing Translational Sciences (NCATS). Prior to joining NCATS, she had over 20 years of industrial experience in drug metabolism and pharmacokinetics. Dr. Xu has extensive experience in IND and NDA filings of novel therapeutics, ranging from small molecules to biologics, such as monoclonal antibody, nanobody, engineered human protein, protein-drug conjugate and gene therapy.
Dr. Xu obtained her B.Sc. degree from School of Pharmacy, Peking University Health Science Center, Beijing, China. She earned her Ph.D. degree in Pharmacokinetics from Faculty of Pharmacy, University of Toronto, where she also did her post-doctoral training in controlled release formulation. Dr. Xu has authored 259 publications (130 journal papers/ book chapters, and 129 conference presentations/abstracts). She is the co-inventor for five patents.
Disclosure information not submitted.
Saturday, February 5, 2022
8:15 AM – 5:00 PM